PMC3920833

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

There was no statistically significant association between serum taurine levels and overall CHD risk. The adjusted odds ratio for CHD in the highest versus lowest tertile of serum taurine was 0.66 (95

Effect: null; OR 0.66; CI: 95% CI 0.39-1.13

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97